MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS PARIETENE; MESH, SURGICAL, POLYMERIC

Model Number	PPM1515X3
Medical Device Problem Codes	Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Device Problem Information (3190); Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes	Abdominal Pain (1685); Adhesion(s) (1695); Erosion (1750); Emotional Changes (1831); Fistula (1862); Inflammation (1932); Muscle Weakness/Atrophy (1967); Necrosis (1971); Pain (1994); Hernia (2240); Obstruction/Occlusion (2422); Unspecified Tissue Injury (4559)
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced disability, impairment, loss of enjoyment of life, mesh failure, adhesions, bowel obstruction, hernia recurrence, pain, inflammation, bowel necrosis, fistula, and bowel erosion.Post-operative patient treatment included mesh removal, bowel resection, bowel deserosalizaion, and enterotomy.
Additional Manufacturer Narrative
Additional information: a4, b5, b7, h6 (added imf code).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an abdominal hernia.It was reported that after implant, the patient experienced disability, impairment, loss of enjoyment of life, mesh failure, adhesions, bowel obstruction, hernia recurrence, pain, inflammation, bowel necrosis, fistula, and bowel erosion.Post-operative patient treatment included mesh removal, bowel resection, bowel deserosalizaion, lysis of adhesions, bone anchors, wound vac, right/left external oblique muscle flap, thoracolumbar perforator fascio cutaneous flap, and enterotomy.
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an abdominal hernia.It was reported that after implant, the patient experienced disability, impairment, loss of enjoyment of life, mesh failure, adhesions, bowel obstruction, hernia recurrence, pain, inflammation, bowel necrosis, fistula, enterotomy, and bowel erosion.Post-operative patient treatment included mesh removal, bowel resection, bowel deserosalizaion, lysis of adhesions, bone anchors, wound vac, right/left external oblique muscle flap, thoracolumbar perforator fascio cutaneous flap, medication, hernia repair with new mesh.
Additional Manufacturer Narrative
Additional information: a2, a3, a4, b5, b7, h6 (patient codes).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an abdominal hernia.It was reported that after implant, the patient experienced disability, impairment, loss of enjoyment of life, mesh failure, adhesions, bowel obstruction, hernia recurrence, pain, inflammation, bowel necrosis, fistula, enterotomy, inflammation, abdominal pain, and bowel erosion.Post-operative patient treatment included mesh removal, bowel resection, bowel deserosalizaion, lysis of adhesions, bone anchors, wound vac, right/left external oblique muscle flap, thoracolumbar perforator fascio cutaneous flap, medication, hernia repair with new mesh.

• Brand Name: PARIETENE
• Common Device Name: MESH, SURGICAL, POLYMERIC
• Manufacturer (Section D): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer (Section G): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer Contact: mike bocchino ; 5920 longbow drive; 8200 coral sea st ne; mounds view,mn, CO 55112--439 ; +1(800)646-4633
• MDR Report Key: 13040564
• Report Number: 9615742-2021-02496
• Device Sequence Number: 5448945
• Product Code: FTL
• UDI-Device Identifier: 20884521213835
• UDI-Public: (01)20884521213835(17)220228(10)SRC0738X
• Combination Product (Y/N): N
• Initial Reporter State: MA
• Initial Reporter Country: US
• PMA/510(K) Number: K142091
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2018
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Consumer
• Initial Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup,Followup,Followup,Followup
• Report Date (Section B): 09/22/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 02/28/2022
• Device Model Number: PPM1515X3
• Device Catalogue Number: PPM1515X3
• Device Lot Number: SRC0738X
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Was the Report Sent to FDA?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 12/01/2021
• Supplement Date Received by Manufacturer: 02/05/2025; 02/19/2025; 04/16/2025; 09/02/2026
• Initial Report FDA Received Date: 12/19/2021
• Supplement Report FDA Received Date: 02/10/2025; 02/19/2025; 04/24/2025; 09/22/2026
• Date Device Manufactured: 03/30/2017
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention; Hospitalization; Disability
• Patient Sex: Female
• Patient Weight: 150 LB
• Patient Race: White